Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies

por Mwakingwe-Omari, Agnes, Lecrenier, Nicolas, Naficy, Abdi, Curran, Desmond, Posiuniene, Inga
Publicado 2023

114. Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after...

por Strezova, Ana, Diez-Domingo, Javier, Shawafi, Kamal Al, Tinoco, Juan Carlos, Shi, Meng, Pirrotta, Paola, Mwakingwe-Omari, Agnes
Publicado 2022

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccinati...

por Strezova, Ana, Diez-Domingo, Javier, Al Shawafi, Kamal, Tinoco, Juan Carlos, Shi, Meng, Pirrotta, Paola, Mwakingwe-Omari, Agnes
Publicado 2022

No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Ag...

por Naficy, Abdi, Kuxhausen, Adrienne, Pirrotta, Paola, Leav, Brett, Miller, Jacqueline, Anteyi, Kate, Danier, Jasur, Breuer, Thomas, Mwakingwe-Omari, Agnes
Publicado 2023